Human Gene Sequencing Markets, Strategies & Trends. Forecasts by Application, by Technology, by Workflow, by Product, and by Country. With Executive and Consultant Guides. 2024 to 2028

Table of Contents

1. Market Guides

• 1.1. Human Gene Sequencing Markets - Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. Gene Sequencing Definition In This Report
  • 2.1.1. Gene Sequencing
  • 2.1.2. Hereditary
  • 2.1.3. Non Invasive Prenatal Testing
  • 2.1.4. Oncology
  • 2.1.5. Psychology
  • 2.1.6. WGES
  • 2.1.7. Pharmacogenomic
  • 2.1.8. Direct to Consumer
  • 2.1.9. Research
  • 2.1.10. Other
• 2.2. The Genomics Revolution
• 2.3. Market Definition
  • 2.3.1. Revenue Market Size
• 2.4. Methodology
  • 2.4.1. Methodology
  • 2.4.2. Sources
  • 2.4.3. Authors
• 2.5. Perspective: Healthcare and the IVD Industry
  • 2.5.1. Global Healthcare Spending
  • 2.5.2. Spending on Diagnostics
  • 2.5.3. Important Role of Insurance for Diagnostics
• 2.6. Chromosomes, Genes and Epigenetics
  • 2.6.1. Chromosomes
  • 2.6.2. Genes
  • 2.6.3. Epigenetics
  • 2.6.4. Genetic Testing vs. Gene Sequencing
  • 2.6.5. Cost and Pricing Practice

3. Global Listing of Sequencer Installed Base - Location & Contacts

• 3.1. Notes to Installed Base Listing
• 3.2. Illumina Installed Base

4. Market Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Instrumentation Supplier
  • 4.1.4. Chemical/Reagent Supplier
  • 4.1.5. Pathology Supplier
  • 4.1.6. Independent Clinical Laboratory
  • 4.1.7. Public National/regional Laboratory
  • 4.1.8. Hospital Laboratory
  • 4.1.9. Physicians Office Lab (POLS)
  • 4.1.10. Audit Body
  • 4.1.11. Certification Body
• 4.2. Human Gene Sequencing -Markets, Examples and Discussion
  • 4.2.1. Inherited Disease - Not what it used to be
    • 4.2.1.1. Clinical and Research Lines Blur
    • 4.2.1.2. Genetic Counselling - Not so simple anymore
    • 4.2.1.3. The Genetic Blizzard - Issues of Access and Payment
  • 4.2.2. Newborn Screening - The Standard of Care
    • 4.2.2.1. Newborn Screening - Do Parents Want to Know?
  • 4.2.3. NIPT - We've Only Just Begun
    • 4.2.3.1. NIPT, IVF and the Fertility Practice - PGS, PGD, CCS
    • 4.2.3.2. NIPT in the Future - Beyond Inherited Disease
  • 4.2.4. Oncology - Understanding Two Worlds
    • 4.2.4.1. The Tumor - A Sequence of Sequencing
    • 4.2.4.2. The Tumor - Biopsy and Liquid Biopsy
    • 4.2.4.3. The Human Genome - Predisposition and Prognosis
  • 4.2.5. Pharmacogenomics
    • 4.2.5.1. Sequencing Not the Only Player
    • 4.2.5.2. New Roles for Old Drugs - A Research Bonanza?
  • 4.2.6. Direct To Consumer - More Than Meets the Eye
    • 4.2.6.1. DTC - How Many Segments?
• 4.3. Industry Structure
  • 4.3.1. Hospital's Testing Share
  • 4.3.2. The Rise of the Sequencing Lab
  • 4.3.3. Sequencing as a Commodity
  • 4.3.4. Informatics
  • 4.3.5. Instrument Manufacturer Role
  • 4.3.6. Healthcare Industry Impacts - Still Struggling
  • 4.3.7. Can the Healthcare Industry Adapt?
  • 4.3.8. Genetic Counselling as an Industry
  • 4.3.9. Sequencing Adoption and Cannibalization

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. New Diagnoses
  • 5.1.2. Wellness and Prevention
  • 5.1.3. Fertility Technology
  • 5.1.4. Cancer - Screening, Management and Monitoring
• 5.2. Factors Limiting Growth
  • 5.2.1. Increased Competition Lowers Price
  • 5.2.2. Lower Costs
  • 5.2.3. Healthcare Cost Concerns Curtail Growth
  • 5.2.4. Wellness has a downside
• 5.3. Sequencing Instrumentation
  • 5.3.1. Instrumentation Tenacity
  • 5.3.2. Declining Cost of Instruments Changes Industry Structure
  • 5.3.3. Long Reads - Further Segmentation
  • 5.3.4. Linked Reads
  • 5.3.5. New Sequencing Technologies

6. Human Gene Sequencing Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. WGS Improves Pediatric Cancer Care
• 6.3. Cancer genomes identify candidate driver genes
• 6.4. Genetic Dx a game changer
• 6.5. Nonacus Galeas Tumor
• 6.6. Lucence LiquidHallmark Assay Gets Coverage
• 6.7. Garvan Institute Gets Gramt to Develop Genomics Tests
• 6.8. Arima Genomics, Protean BioDiagnostics Launch Joint Venture
• 6.9. Geneseeq Nabs CE Marks for Cancer Test Kits
• 6.10. Viome Life Sciences Announces Gut Intelligence Test
• 6.11. Quest Diagnostics Announces Genetic Insights
• 6.12. Exact Sciences Releases Next-Gen Cologuard
• 6.13. BGI Genomics Forges Partnerships in Latin America
• 6.14. 4bases Bets on NGS Diagnostics
• 6.15. Guardant Health Submits Colorectal Cancer Screening Test
• 6.16. Universal DX Eyeing Approval for Colorectal Cancer Screening Test
• 6.17. Natera Files Suit Against NeoGenomics
• 6.18. Genomics England to Sequence 100K Newborns
• 6.19. Novigenix Raises $14M for NGS based Liquid Biopsy
• 6.20. LetsGetChecked Launching New PGx Service
• 6.21. Qiagen, Neuron23 Partner for NGS Diagnostic
• 6.22. Harbinger Health Technology Focused On Oncogenesis
• 6.23. Delfi Diagnostics to Develop Early Detection Test
• 6.24. Dante Labs to Introduce WGS to Italian Healthcare System
• 6.25. Invitae Neurodevelopmental Disorders Testing Service
• 6.26. Thermo Fisher Obtains CE Mark for Ion Torrent Genexus
• 6.27. Myriad Genetics Launches Suite of Cancer Tests
• 6.28. Oncocyte and Thermo Fisher Strike Partnership Deal
• 6.29. Illumina Partners With Precision Medicine to Assess Liquid Biopsy
• 6.30. Sysmex Inostics Develops Ultra-Sensitive Liquid Biopsy
• 6.31. Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Testing
• 6.32. Strata Oncology Trial Supports NGS Assay
• 6.33. NYU Gets FDA Clearance for Sequencing Test
• 6.34. NeoGenomics to Acquire Inivata
• 6.35. OncoDNA, Institut Curie Partner on Liquid Biopsy Research
• 6.36. Cancer Heritability Gene Set Expanded
• 6.37. Whole-Genome Sequencing Could Replace Cytogenetics
• 6.38. Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays
• 6.39. Ancestry Shutters Health Offering
• 6.40. Genetron Health Targeting Early Cancer Detection
• 6.41. Pan-European Initiative to Build Tools for Sharing Genomic Data
• 6.42. UK Government Unveils New Genomic Healthcare Strategy
• 6.43. Foundation Medicine Liquid Biopsy Gets FDA Approval
• 6.44. American Heart Association Develops Genetic Testing Guidelines
• 6.45. Yourgene Health Gets CE Mark for Iona NIPT Test
• 6.46. NorthShore Looks to Expand Genomics Integration Into Primary Care
• 6.47. Germline Results From Tumor Sequencing Guides Precision Therapy
• 6.48. FDA Clears Cancer Genomic Profiling From Personal Genome Diagnostics
• 6.49. BillionToOne Closes $15M Series A Follow-on Round
• 6.50. Clinics to Integrate Genomics Into Primary Care

7. Profiles of Key Companies

• 7.1 10x Genomics, Inc.
• 7.2 23andME Inc.
• 7.3. Abbott Laboratories
• 7.4. AccuraGen Inc.
• 7.5. Adaptive Biotechnologies
• 7.6. Admera Health, LLC
• 7.7. Advanced Biological Laboratories
• 7.8. Agilent
• 7.9. Akonni Biosystems
• 7.10. Amoy Diagnostics Co., Ltd.
• 7.11. Ancestry.com LLC
• 7.12. Anchor Dx
• 7.13. Arrayit Corporation
• 7.14. ARUP Laboratories
• 7.15. Astrid Bio
• 7.16. Azenta
• 7.17. BaseClear
• 7.18. Baylor Miraca Genetics Laboratories
• 7.19. Beckman Coulter Diagnostics (Danaher)
• 7.20. Becton, Dickinson and Company
• 7.21. BGI Genomics Co. Ltd
• 7.22. Bioarray Genetics
• 7.23. BioBam
• 7.24. Biocept, Inc.
• 7.25. Biodesix Inc.
• 7.26. BioFluidica
• 7.27. BioGenex
• 7.28. Biolidics Ltd
• 7.29. bioMerieux Diagnostics
• 7.30. Bioneer Corporation
• 7.31. Bio-Rad Laboratories, Inc.
• 7.32. Bio-Techne
• 7.33. Burning Rock
• 7.34. C2i Genomics
• 7.35. Cantata Bio
• 7.36. CareDx
• 7.37. Caris Molecular Diagnostics
• 7.38. Celemics
• 7.39. CellMax Life
• 7.40. Centogene
• 7.41. Cepheid (Danaher)
• 7.42. Circulogene
• 7.43. Clearbridge Biomedics
• 7.44. Clinical Genomics
• 7.45. Color Genomics
• 7.46. Complete Genomics (MGI Tech)
• 7.47. CosmosID
• 7.48. Dante Labs
• 7.49. Datar Cancer Genetics Limited
• 7.50. Diasorin S.p.A.
• 7.51. Easy DNA
• 7.52. Element Biosciences
• 7.53. Epic Sciences
• 7.54. Epigenomics AG
• 7.55. Eurofins Scientific
• 7.56. Excellerate Bioscience
• 7.57. Fabric Genomics
• 7.58. Freenome
• 7.59. FUJIFILM Wako Diagnostics
• 7.60. Fujirebio
• 7.61. Fulgent Genetics
• 7.62. GE Global Research
• 7.63. Gene by Gene, Ltd.
• 7.64. Genedrive
• 7.65. GeneDx Holdings
• 7.66. GeneFirst Ltd.
• 7.67. GeneFluidics
• 7.68. Genetron Holdings
• 7.69. Genewiz
• 7.70. Genomics England
• 7.71. Genomics Personalized Health (GPH)
• 7.72. GenomOncology
• 7.73. Genzyme Corporation
• 7.74. Grifols
• 7.75. Guardant Health
• 7.76. Guardiome
• 7.77. Helix
• 7.78. Hologic
• 7.79. HTG Molecular Diagnostics
• 7.80. Human Longevity, Inc.
• 7.81. iCellate
• 7.82. Illumina
• 7.83. Incell Dx
• 7.84. Inivata
• 7.85. Invitae Corporation
• 7.86. Invivoscribe
• 7.87. Karius
• 7.88. Letsgetchecked
• 7.89. Lucence Health
• 7.90. Lunglife AI Inc
• 7.91. Macrogen
• 7.92. MDNA Life SCIENCES, Inc.
• 7.93. MDx Health
• 7.94. Medgenome
• 7.95. Meridian Bioscience
• 7.96. Mesa Laboratories, Inc.
• 7.97. Metabiomics Corp
• 7.98. miR Scientific
• 7.99. NantHealth, Inc.
• 7.100. Natera
• 7.101. Nebula Genomics
• 7.102. NeoGenomics
• 7.103. New England Biolabs, Inc.
• 7.104. NGeneBio
• 7.105. Norgen Biotek Corp.
• 7.106. Novogene
• 7.107. Omega Bioservices
• 7.108. Oncocyte
• 7.109. OncoDNA
• 7.110. OpGen
• 7.111. Origene Technologies
• 7.112. Oxford Nanopore Technologies
• 7.113. Pacific Biosciences
• 7.114. Panagene
• 7.115. PathoQuest S.A.
• 7.116. Personalis
• 7.117. PGDx (Labcorp)
• 7.118. Precipio
• 7.119. PrecisionMed
• 7.120. Predictive Oncology
• 7.121. Promega
• 7.122. Qiagen
• 7.123. QuantuMDx
• 7.124. Regeneron Pharmaceuticals
• 7.125. Revvity
• 7.126. Roche Diagnostics
• 7.127. Roswell Biotechnologies
• 7.128. Seegene
• 7.129. SeLux Diagnostics
• 7.130. Sequencing.com
• 7.131. Siemens Healthineers
• 7.132. simfo GmbH
• 7.133. Singlera Genomics Inc.
• 7.134. Singular Genomics
• 7.135. SkylineDx
• 7.136. Standard BioTools
• 7.137. Sysmex
• 7.138. Sysmex Inostics
• 7.139. Tempus Labs, Inc.
• 7.140. Thermo Fisher Scientific
• 7.141. Ultima Genomics
• 7.142. Unchained Labs
• 7.143. Variantyx
• 7.144. Vela Diagnostics
• 7.145. VolitionRX
• 7.146. Zymo Research Corp

8. The Global Market for Human Genome Sequencing

• 8.1. Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market by Application - Overview
  • 8.2.1. Table - Global Market by Application
  • 8.2.2. Chart - Global Market by Application - Base/Final Year Comparison
  • 8.2.3. Chart - Global Market by Application - Base Year
  • 8.2.4. Chart - Global Market by Application - Final Year
  • 8.2.5. Chart - Global Market by Application - Share by Year
  • 8.2.6. Chart - Global Market by Application - Segment Growth
• 8.3. Global Market by Technology - Overview
  • 8.3.1. Table - Global Market by Technology
  • 8.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
  • 8.3.3. Chart - Global Market by Technology - Base Year
  • 8.3.4. Chart - Global Market by Technology - Final Year
  • 8.3.5. Chart - Global Market by Technology - Share by Year
  • 8.3.6. Chart - Global Market by Technology - Segment Growth
• 8.4. Global Market by Workflow - Overview
  • 8.4.1. Table - Global Market by Workflow
  • 8.4.2. Chart - Global Market by Workflow - Base/Final Year Comparison
  • 8.4.3. Chart - Global Market by Workflow - Base Year
  • 8.4.4. Chart - Global Market by Workflow - Final Year
  • 8.4.5. Chart - Global Market by Workflow - Share by Year
  • 8.4.6. Chart - Global Market by Workflow - Segment Growth
• 8.5. Global Market by Product - Overview
  • 8.5.1. Table - Global Market by Product
  • 8.5.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 8.5.3. Chart - Global Market by Product - Base Year
  • 8.5.4. Chart - Global Market by Product - Final Year
  • 8.5.5. Chart - Global Market by Product - Share by Year
  • 8.5.6. Chart - Global Market by Product - Segment Growth

9. Market Sizes by Application

• 9.1. Hereditary Gene Sequencing Market
  • 9.1.1. Table - Hereditary by Country
  • 9.1.2. Chart - Hereditary Segment Growth
• 9.2. NIPT Gene Sequencing Market
  • 9.2.1. Table NIPT by Country
  • 9.2.2. Chart - NIPT Growth
• 9.3. Oncology Market
  • 9.3.1. Table - Oncology by Country
  • 9.3.2. Chart - Oncology Growth
• 9.4. Psychology Market
  • 9.4.1. Table - Psychology by Country
  • 9.4.2. Chart - Psychology Growth
• 9.5. WGES Gene Sequencing Market
  • 9.5.1. Table - WGES by Country
  • 9.5.2. Chart - WGES growth
• 9.6. Pharmacogenomics Market
  • 9.6.1. Table Pharmacogenomics by Country
  • 9.6.2. Chart - Pharmacogenomics Growth
• 9.7. DTC Gene Sequencing Market
  • 9.7.1. Table - DTC by Country
  • 9.7.2. Chart - DTC Growth
• 9.8. Research Gene Sequencing Market
  • 9.8.1. Table - Research by Country
  • 9.8.2. Chart - Research Growth
• 9.9. Other Application Market
  • 9.9.1. Table - Other Application by Country
  • 9.9.2. Chart - Other Application growth

10. Market Sizes by Technology

• 10.1. Sanger Sequencing Market
  • 10.1.1. Table - Sanger by Country
  • 10.1.2. Chart - Sanger Segment Growth
• 10.2. NGS/2G Market
  • 10.2.1. Table NGS/2G by Country
  • 10.2.2. Chart - NGS/2G Growth
• 10.3 3G/Long Market
  • 10.3.1. Table - 3G/Long by Country
  • 10.3.2. Chart - 3G/Long Growth
• 10.4. Other Technology Market
  • 10.4.1. Table - Other Technology by Country
  • 10.4.2. Chart - Other Technology Growth

11. Market Sizes by Workflow

• 11.1. Sequencing Market
  • 11.1.1. Table - Sequencing by Country
  • 11.1.2. Chart - Sequencing Segment Growth
• 11.2. Sample Prep Market
  • 11.2.1. Table Sample Prep by Country
  • 11.2.2. Chart - Sample Prep Growth
• 11.3. Analysis Market
  • 11.3.1. Table - Analysis by Country
  • 11.3.2. Chart - Analysis Growth

12. Market Sizes by Product

• 12.1. Instruments Market
  • 12.1.1. Table - Instruments by Country
  • 12.1.2. Chart - Instruments Segment Growth
• 12.2. Consumables Market
  • 12.2.1. Table Consumables by Country
  • 12.2.2. Chart - Consumables Growth
• 12.3. Software & Services Market
  • 12.3.1. Table - Software & Services by Country
  • 12.3.2. Chart - Software & Services Growth

13. Vision of the Future of Human Gene Sequencing

14. Appendices

• 14.1. Growth of Approved IVD Test Menu
• 14.2. Growth of Approved Average IVD Test Fee
• 14.3. The Most Used IVD Assays
• 14.4. The Highest Grossing Assays
• 14.5. Laboratory Fees Schedule
• 14.6. The Whole Genome Sequence of SARS-CoV-2

Tables

• Table 1: The Base Pairs
• Table 2: Most Common Traditional Genetic Disorders
• Table 3: The Base Pairs
• Table 4: List of GLOBAL SEQUENCING LOCATIONS
• Table 5: Market Players by Type
• Table 6: The Different Markets for Human Gene Sequencing
• Table 7: DTC Sub Segments
• Table 8: The Factors Driving Growth
• Table 9: Factors Limiting Growth
• Table 10: Six New Sequencing Technologies
• Table 11: Global Market by Region
• Table 12: Global Market by Application
• Table 13: Global Market by Technology
• Table 14: Global Market by Workflow
• Table 15: Global Market by Product
• Table 16: Hereditary Segment by Country
• Table 17: NIPT Segment by Country
• Table 18: Oncology Segment by Country
• Table 19: Psychology Segment by Country
• Table 20: WGES Segment by Country
• Table 21: Pharmacogenomics Segment by Country
• Table 22: DTC Segment by Country
• Table 23: Research Segment by Country
• Table 24: Other Application Segment by Country
• Table 25: Sanger Segment by Country
• Table 26: NGS/2G Segment by Country
• Table 27: 3G/Long Segment by Country
• Table 28: Other Technology by Country
• Table 29: Sequencing Segment by Country
• Table 30: Sample Prep Segment by Country
• Table 31: Analysis Segment by Country
• Table 32: Instruments Segment by Country
• Table 33: Consumables Segment by Country
• Table 34: Software & Services Segment by Country
• Table 35: The Most Common Assays
• Table 36: Largest Revenue Assays
• Table 37: Clinical Lab Fee Schedule

Figures

• Figure 1: Global Healthcare Spending
• Figure 2: The Lab Test Pie
• Figure 3: DNA Strands and Chromosomes
• Figure 4: Karyogram of Human Chromosomes
• Figure 5: Size of Various Genomes
• Figure 6: Global Illumina Installed Base Map
• Figure 7: The Road to Diagnostics
• Figure 8: TruSight Germline Panel
• Figure 9: Historical Cost of Gene Sequencing
• Figure 10: Cost To Sequence a Human Genome
• Figure 11: Base Year Country Market Share Chart
• Figure 12: Global Market by Application - Base vs. Final Year
• Figure 13: Global Market by Application Base Year
• Figure 14: Global Market by Application Final Year
• Figure 15: Application Type Share by Year
• Figure 16: by Application Segment Growth
• Figure 17: Global Market by Technology - Base vs. Final Year
• Figure 18: Global Market by Technology Base Year
• Figure 19: Global Market by Technology Final Year
• Figure 20: Technology Type Share by Year
• Figure 21: by Technology Segment Growth
• Figure 22: Global Market by Workflow - Base vs. Final Year
• Figure 23: Global Market by Workflow Base Year
• Figure 24: Global Market by Workflow Final Year
• Figure 25: Workflow Type Share by Year
• Figure 26: by Workflow Segment Growth
• Figure 27: Global Market by Product - Base vs. Final Year
• Figure 28: Global Market by Product Base Year
• Figure 29: Global Market by Product Final Year
• Figure 30: Product Type Share by Year
• Figure 31: by Product Segment Growth
• Figure 32: Hereditary vs. Total Market Growth
• Figure 33: NIPT vs. Total Market Growth
• Figure 34: Oncology vs. Total Market Growth
• Figure 35: Psychology vs. Total Market Growth
• Figure 36: WGES vs. Total Market Growth
• Figure 37: Pharmacogenomics vs. Total Market Growth
• Figure 38: DTC vs. Total Market Growth
• Figure 39: Research vs. Total Market Growth
• Figure 40: Other Application vs. Total Market Growth
• Figure 41: Sanger vs. Total Market Growth
• Figure 42: NGS/2G vs. Total Market Growth
• Figure 43: 3G/Long vs. Total Market Growth
• Figure 44: Other Technology vs. Total Market Growth
• Figure 45: Sequencing vs. Total Market Growth
• Figure 46: Sample Prep vs. Total Market Growth
• Figure 47: Analysis vs. Total Market Growth
• Figure 48: Instruments vs. Total Market Growth
• Figure 49: Consumables vs. Total Market Growth
• Figure 50: Software & Services vs. Total Market Growth
• Figure 51: IVD Test Menu Growth
• Figure 52: IVD Test Average Fees - A Ten Year View